INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

19,342 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$9,073
476 sh
Feb 23, 2026Feb 24, 2026
Page 340 of 484
← PrevNext →
traded Feb 23, 2026
+1d
SEC Form 4

Evidence

14
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$13K
736 sh
Feb 24, 2026Feb 24, 2026
traded Feb 24, 2026
+0dSEC Form 4

Evidence

14
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$40K
2,195 sh
Feb 20, 2026Feb 24, 2026
traded Feb 20, 2026
+4dSEC Form 4

Evidence

14
MN
Mac Ban Ryan NorrisChief Revenue Officer
CFLTConfluent, Inc.
Open-market sale · 10b5-1 plan
SELL$354K
11.5K sh
Feb 20, 2026Feb 24, 2026
traded Feb 20, 2026
+4dSEC Form 4

Evidence

49
CS
Congdon David SDirector, Executive Chairman
ODFLOLD DOMINION FREIGHT LINE, INC.
Open-market sale
SELL$8.18M
42.0K sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

45
CS
Congdon David SDirector, Executive Chairman
ODFLOLD DOMINION FREIGHT LINE, INC.
Open-market sale
SELL$1.95M
10.0K sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

43
BE
Bechelany Pierre EdwardGroup President
FLRFLUOR CORP
Open-market sale
SELL$243K
4,581 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

43
HB
Hammonds Kevin BCHIEF LEGAL OFFICER
FLRFLUOR CORP
Open-market sale
SELL$157K
2,988 sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

41
BH
Barbacovi HollyChief People Officer
HASHASBRO, INC.
Open-market sale
SELL$438K
4,337 sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

39
PM
Pinard MattsEVP, CFO AND TREASURER
STAGSTAG Industrial, Inc.
Open-market sale
SELL$989K
25.2K sh
Feb 23, 2026Feb 23, 2026
traded Feb 23, 2026
+0dSEC Form 4

Evidence

34
NJ
Nicholas Christopher JamesExecutive Vice President
WMTWalmart Inc.
Open-market sale
SELL$4.16M
34.1K sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

32
SB
Stefanski Gavin BChief Experience Officer
TFSLTFS Financial CORP
Open-market sale
SELL$105K
7,000 sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

26
MR
Mink RobinEVP/Chief TM Officer
CCNECNB FINANCIAL CORP/PA
Open-market sale
SELL$3,989
144 sh
Feb 23, 2026Feb 23, 2026
traded Feb 23, 2026
+0dSEC Form 4

Evidence

26
WD
Wilcoxson Angela D.EVP/Chief Commercial Banking
CCNECNB FINANCIAL CORP/PA
Open-market sale
SELL$9,113
329 sh
Feb 23, 2026Feb 23, 2026
traded Feb 23, 2026
+0dSEC Form 4

Evidence

24
LA
Leggett Michael AdamSr VP & Chief Supply Chain Off
LZBLA-Z-BOY INC
Open-market sale
SELL$81K
2,200 sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

24
WR
Webb Michael ReedSVP & Chief Admin Officer
ROGROGERS CORP
Open-market sale
SELL$72K
673 sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

21
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$136K
5,227 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

21
TM
Tappin MatthewPresident, Software Products
STEMSTEM, INC.
Open-market sale
SELL$4,172
366 sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

20
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$167K
3,258 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
1,492 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

16
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$61K
1,217 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

4
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$162K
2,084 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

4
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$135K
1,730 sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

42
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale
SELL$595K
10.1K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

35
FR
Fukushima RyanChief Executive Officer, Data
TEMTempus AI, Inc.
Open-market sale
SELL$566K
9,592 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

33
LR
Lerner Lorena RaquelChief Science Officer
KROSKeros Therapeutics, Inc.
Open-market sale
SELL$63K
3,873 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

33
CE
Cho EstherSVP, General Counsel
KROSKeros Therapeutics, Inc.
Open-market sale
SELL$78K
4,745 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

31
TJ
Tasker Anthony JamesSVP & COO
FUNCFIRST UNITED CORP/MD/
Open-market sale
SELL$33.11
1 sh
Feb 4, 2026Feb 20, 2026
traded Feb 4, 2026
+16dSEC Form 4

Evidence

29
CG
Casella Matthew G.Former officer
RRRICHTECH ROBOTICS INC.
Open-market sale
SELL$34K
12.5K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
CG
Campbell Darrell GeorgeEVP - CFO
SNDRSchneider National, Inc.
Open-market sale
SELL$173K
6,000 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
GS
Griffis SarahChief Technology Officer
MAPSWM TECHNOLOGY, INC.
Open-market sale
SELL$183K
271.0K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

28
WR
Webb Michael ReedSVP & Chief Admin Officer
ROGROGERS CORP
Open-market sale
SELL$127K
1,197 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

26
PE
Phelps ErikEVP, Chief Admin. Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$334K
5,650 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

25
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$65K
10.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

23
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$481K
8,143 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

23
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$654K
10.8K sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

22
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$56K
698 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

22
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$58K
711 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

22
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$19K
3,016 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
AR
Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER
ANNXAnnexon, Inc.
Open-market sale
SELL$27K
5,290 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence